Sanhuangjingshimingwan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sanhuangjingshimingwan, covering 2022-11-25 to 2022-11-25. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects [Phase 2]